vimarsana.com

Latest Breaking News On - Jim hippel - Page 1 : vimarsana.com

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.

South koreaUnited statesJim hippelWilliam blairKim keldermanCatherine schulteMatt larewPuneet soudaWilson wolfPatrick donnellyJacob johnsonBio techne rnascope hiplexDavid clairJustin bowersDan ariasOur protein sciences

Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript

Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024.

New yorkUnited statesSouth koreaCharles kummethDaniel ariasDavid clairJim hippelJames hippelWilson wolfg rexChuck kummethKim keldermanPuneet soudaRnascope hippleWilson wolfDan ariasProtein sciences

BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at.

David clairJim hippelPrnewswire bio techne corporationProtein sciences segmentBio techne corporationInvestor relations corporate developmentTechne corporationExecutive vice presidentChief financial officerGenomics summitInvestor relationsProtein sciencesVice president

BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE

MINNEAPOLIS, May 25, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 Jefferies Healthcare. | May 25, 2023

Jim hippelDavid clairPrnewswire bio techne corporationProtein sciences segmentInvestor relations corporate developmentBio techne corporationTechne corporationExecutive vice presidentChief financial officerHealthcare conferenceInvestor relationsProtein sciencesVice presidentBio techne corporation stock exchangePress releaseEfferies tech us09073m1045

BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

MINNEAPOLIS, May 12, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets. | May 12, 2023

David clairJim hippelInvestor relations corporate developmentBio techne corporationPrnewswire bio techne corporationProtein sciences segmentTechne corporationExecutive vice presidentChief financial officerMarkets global healthcare conferenceInvestor relationsProtein sciencesVice presidentBio techne corporation stock exchangePress releaseApital tech us09073m1045

vimarsana © 2020. All Rights Reserved.